FR2374915A1 - Preparation pharmaceutique ophtalmique a liberation lente contenant des collagenes et procede pour sa preparation - Google Patents
Preparation pharmaceutique ophtalmique a liberation lente contenant des collagenes et procede pour sa preparationInfo
- Publication number
- FR2374915A1 FR2374915A1 FR7715385A FR7715385A FR2374915A1 FR 2374915 A1 FR2374915 A1 FR 2374915A1 FR 7715385 A FR7715385 A FR 7715385A FR 7715385 A FR7715385 A FR 7715385A FR 2374915 A1 FR2374915 A1 FR 2374915A1
- Authority
- FR
- France
- Prior art keywords
- preparation
- slow
- ophthalmic pharmaceutical
- collagen
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title abstract 5
- 108010035532 Collagen Proteins 0.000 title abstract 5
- 229920001436 collagen Polymers 0.000 title abstract 5
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000006185 dispersion Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 abstract 1
- 229930182837 (R)-adrenaline Natural products 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 abstract 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002876 beta blocker Substances 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960005139 epinephrine Drugs 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract 1
- 239000001685 glycyrrhizic acid Substances 0.000 abstract 1
- 235000019410 glycyrrhizin Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 229960004716 idoxuridine Drugs 0.000 abstract 1
- 230000003547 miosis Effects 0.000 abstract 1
- 239000003604 miotic agent Substances 0.000 abstract 1
- 239000002637 mydriatic agent Substances 0.000 abstract 1
- 230000002911 mydriatic effect Effects 0.000 abstract 1
- 229940023490 ophthalmic product Drugs 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 229960003636 vidarabine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51057298A JPS597684B2 (ja) | 1976-05-20 | 1976-05-20 | コラ−ゲンを用いた眼用徐放性制御医薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2374915A1 true FR2374915A1 (fr) | 1978-07-21 |
| FR2374915B1 FR2374915B1 (https=) | 1981-12-11 |
Family
ID=13051636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7715385A Granted FR2374915A1 (fr) | 1976-05-20 | 1977-05-18 | Preparation pharmaceutique ophtalmique a liberation lente contenant des collagenes et procede pour sa preparation |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS597684B2 (https=) |
| DE (1) | DE2719770C3 (https=) |
| ES (1) | ES459244A1 (https=) |
| FR (1) | FR2374915A1 (https=) |
| GB (1) | GB1556097A (https=) |
| SE (1) | SE425592B (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2464962A1 (fr) * | 1979-09-12 | 1981-03-20 | Seton Co | Procede de production d'un collagene macromoleculaire biologiquement actif et produit obtenu |
| EP0037622A3 (en) * | 1980-04-07 | 1981-11-11 | Alza Corporation | Drug delivery insert for controlled ocular therapy |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56122317A (en) * | 1980-02-29 | 1981-09-25 | Koken:Kk | Drug transporting material and its preparation |
| JPS5755146A (en) * | 1980-09-17 | 1982-04-01 | Koken Kk | Drug conveyor |
| JPS60214730A (ja) * | 1984-04-05 | 1985-10-28 | Grelan Pharmaceut Co Ltd | 軟膏基剤 |
| IL95942A0 (en) * | 1989-10-13 | 1991-07-18 | Syntex Inc | Collagen-containing ophthalmic formulation |
| DE4414755C2 (de) * | 1994-04-27 | 2000-11-16 | Lohmann Therapie Syst Lts | Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung |
-
1976
- 1976-05-20 JP JP51057298A patent/JPS597684B2/ja not_active Expired
-
1977
- 1977-04-28 GB GB17714/77A patent/GB1556097A/en not_active Expired
- 1977-05-03 DE DE2719770A patent/DE2719770C3/de not_active Expired
- 1977-05-17 SE SE7705812A patent/SE425592B/xx not_active IP Right Cessation
- 1977-05-18 ES ES459244A patent/ES459244A1/es not_active Expired
- 1977-05-18 FR FR7715385A patent/FR2374915A1/fr active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2464962A1 (fr) * | 1979-09-12 | 1981-03-20 | Seton Co | Procede de production d'un collagene macromoleculaire biologiquement actif et produit obtenu |
| EP0037622A3 (en) * | 1980-04-07 | 1981-11-11 | Alza Corporation | Drug delivery insert for controlled ocular therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| SE7705812L (sv) | 1977-11-21 |
| JPS52143216A (en) | 1977-11-29 |
| SE425592B (sv) | 1982-10-18 |
| JPS597684B2 (ja) | 1984-02-20 |
| DE2719770B2 (de) | 1980-05-29 |
| ES459244A1 (es) | 1979-06-01 |
| FR2374915B1 (https=) | 1981-12-11 |
| DE2719770A1 (de) | 1977-12-08 |
| GB1556097A (en) | 1979-11-21 |
| DE2719770C3 (de) | 1981-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3750943T2 (de) | Teilchenzubereitung mit verzögerter Wirkstoffabgabe und deren Zubereitungsmethode. | |
| Kramer | Dopamine: A retinal neurotransmitter: I. Retinal uptake, storage, and light-stimulated release of H3-dopamine in vivo | |
| Newsome et al. | Human massive periretinal proliferation: In vitro characteristics of cellular components | |
| US4179497A (en) | Solid state ophthalmic medication | |
| FR2374915A1 (fr) | Preparation pharmaceutique ophtalmique a liberation lente contenant des collagenes et procede pour sa preparation | |
| US4115544A (en) | Ocular system made of bioerodible esters having linear ether | |
| HUT66863A (en) | Process for preparation of oxadiazole and tiadiazole derivatives and pharmaceutical compositions containing them | |
| NO302414B1 (no) | Analogifremgangsmåte for fremstilling av heterocykliske forbindelser | |
| FR2579895A1 (https=) | ||
| EP0384288A3 (en) | Piperidine compounds and their preparation and use | |
| FI902258A0 (fi) | Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi | |
| ATE186916T1 (de) | Hochreactive estern von karboxylgruppen enthaltenden polysachariden und die daraus hergestellte carboxypolysaccharide | |
| Robertson | Electron microscopy of the motor end-plate and the neuromuscular spindle | |
| FR2448347A1 (fr) | Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques | |
| ES8507573A1 (es) | Procedimiento para la fabricacion de fracciones de acido hialuronico | |
| IL99146A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| FI954130A0 (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| Bornstein et al. | Observations on the appearance of neuromuscular relationships in cultured mouse tissues | |
| Sun et al. | Extracellular cross-striated banded structures in human connective tissue | |
| CA1063022A (en) | Solid state ophthalmic medication | |
| FR2434162A1 (fr) | Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant | |
| EP0138720A3 (fr) | Nouveaux benzenesulfonamides n-cyclises, leur procédé de préparation et leur utilisation comme substance active de compositions pharmaceutiques | |
| FR2624508B1 (fr) | Nouveaux derives tertiobutyles du benzylidene camphre, leur procede de preparation, leur utilisation en tant qu'agents anti-oxydants et compositions cosmetiques et pharmaceutiques les contenant | |
| FR2359607A1 (fr) | Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active | |
| Yue et al. | Effects of chondroitin sulfate on metabolism of trabecular meshwork |